Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 4—April 2006

HIV-1 CRF07_BC Infections, Injecting Drug Users, Taiwan

Cite This Article

To the Editor: To date, Taiwan's human immunodeficiency virus type 1 (HIV-1) epidemic has primarily spread via sexual contact. The subtype B and circulating recombinant form (CRF) 01_AE account for >95% of all infections (1). However, since 2003 Taiwan has experienced a major outbreak of CRF07_BC among injecting drug users (IDUs).

The first wave of HIV-1 infections in Taiwan can be traced to the early 1980s, when a group of hemophilia patients received imported HIV-1-contaminated antihemophilia medications. By the time these medications had been replaced by heat-treated factor VIII concentrates, at least 53 patients had contracted HIV-1 infections (2). According to Taiwan's Center for Disease Control (CDC), HIV infections have been diagnosed in 9,229 persons (including 523 foreigners) as of July 31, 2005 (3). The number of persons living with HIV-1/AIDS has increased rapidly in the past few years, with a 77% increase in 2004, compared to 11% in 2003 (Table). According to the results of a risk factor analysis of people living with HIV-1/AIDS reported to the Taiwan CDC, the proportion of IDUs increased from 1.7% (13/773) in 2002 to 8.1% (70/861) in 2003 to 30.3% (462/1,521) in 2004 (Table). The Taiwan CDC received reports of 1,241 IDUs diagnosed with HIV-1 infections from January 1 to July 31, 2005; these account for >75% of all reported HIV-1 infections in 2005 (3). The evidence points to an explosive epidemic of HIV-1 infections among IDUs in Taiwan since 2003, with no indication of a slowdown.

Taiwan has ≈60,000 IDUs (1). According to the Republic of China Ministry of Justice, the number of incarcerated drug offenders increased from 5,988 in 2003 to 9,303 in 2004; the rate of HIV-1 seropositive inmates increased from 13.3/100,000 in 2002 to 56.8/100,000 in 2004 (Y-M. Wu, Ministry of Justice, pers. comm.). Since all inmates are routinely tested for HIV-1 in detention centers, and all infected inmates are separated from HIV-1-seronegative inmates, the potential of HIV-1 transmission in prisons is remote. We therefore suggest that the Taiwanese IDU population and its HIV-1 seropositive rate have both increased rapidly in the past few years.


Thumbnail of Phylogenetic analyses of 7 HIV-1 isolates identified in Taiwan. TW-7496, TW-D16, TW-D17, and TW-D22 were collected from detention center inmates; TW-9541 and TW-9539 were collected from a blood donor and 1 of his donation recipients. This neighbor-joining tree was created from 100 bootstrap samples of aligned env sequences corresponding to the 7077–7340 nucleotide residues of HIV-1-HXB2 from different isolates. Bootstrap values are shown on branch nodes. Reference isolates from the

Figure. Phylogenetic analyses of 7 HIV-1 isolates identified in Taiwan. TW-7496, TW-D16, TW-D17, and TW-D22 were collected from detention center inmates; TW-9541 and TW-9539 were collected from a blood donor and 1...

To identify the primary HIV-1 strains in the current epidemic, we collected blood specimens from HIV-1-infected inmates in 3 detention centers (1 each located in the northern, central and southern regions of Taiwan). HIV-1 subtypes were determined by polymerase chain reaction, DNA sequencing, and phylogenetic analyses of pol or env genes. Our results indicate that 145 (96%) of 151 IDUs were infected with CRF07_BC and 6 (4%) were infected with subtype B; 97% of the CRF07_BC cases were diagnosed in 2003 or 2004. According to our phylogenetic analysis of the env gene, the Taiwanese CRF07_BC strains clustered with CRF07_BC strains drawn from IDUs in China (Figure).

CRF07_BC is a recombinant of the B´ and C subtypes. Several studies have suggested that CRF07_BC originated in China's Yunnan Province, with subtype B´ from Thailand mixing with subtype C from India before moving northwestward to Xinjiang Province along a major Chinese heroin trafficking route (46). To our knowledge, this is the first report of a large group of IDUs in northeastern Asia having CRF07_BC infections. It may have followed another drug trafficking route from Yunnan Province to southeast China, moving through Guangxi Province and Hong Kong to Taiwan (79). In a bid to combat skyrocketing HIV/AIDS infection rates among IDUs, the Taiwan CDC has proposed a 5-year harm reduction program to the Republic of China Executive Yuan.



We thank Yi-Ru Chang for her technical assistance, the Sequencing Core Facility of National Yang-Ming University's Genome Research Center for its technical assistance, and professor Kathleen Ahrens of National Taiwan University for her help in preparing this letter.

This research is partially supported by funds from the AIDS Molecular Virology Laboratory Program of the Taiwan CDC (CDC-94-RM-102, DOH93-DC-1043) and the ROC National Science Council's National Research Program for Genomic Medicine (95-0324-19-F-01-00-00-00-35).


Yi-Ming Arthur Chen*Comments to Author , Yu-Ching Lan*, Shu-Fen Lai*, Jyh-Yuan Yang†, Su-Fen Tsai†, and Steve Hsu-Sung Kuo†
Author affiliations: *National Yang-Ming University, Taipei, Taiwan, Republic of China; †Center for Disease Control, Taipei, Taiwan, Republic of China



  1. Chen  YM, Huang  KL, Jen  I, Chen  SC, Liu  YC, Chuang  YC, Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998. J Acquir Immune Defic Syndr. 2001;26:27482. DOIPubMedGoogle Scholar
  2. Shen  MC, Liu  FY, Kuo  YP, Hsie  RF. A longitudinal study of immunological status in Chinese hemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates. Haemophilia. 1995;1:2438. DOIGoogle Scholar
  3. Republic of China Center for Disease Control, Department of Health. Reported cases of HIV/AIDS by year in Taiwan 1984-2004. 2005. [cited 2005 Jul 31]. Available from
  4. Su  L, Graf  M, Zhang  Y, von Briesen  H, Xing  H, Köstler  J, Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol. 2000;74:1136776. DOIPubMedGoogle Scholar
  5. Yang  R, Xia  X, Kusagawa  S, Zhang  C, Ben  K, Takebe  Y. On-going generation of multiple forms of HIV-1 intersubypte recombinants in the Yunnan province of China. AIDS. 2002;16:14017. DOIPubMedGoogle Scholar
  6. Zhang  L, Chen  Z, Cao  Y, Yu  J, Li  G, Yu  W, Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and infecting drug users in China. J Virol. 2004;78:135919. DOIPubMedGoogle Scholar
  7. Piyasirisilp  S, McCutchan  FE, Carr  JK, Anders-Buell  E, Liu  W, Chen  J, A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol. 2000;74:1128695. DOIPubMedGoogle Scholar
  8. Cohen  J. Asia and Africa: on different trajectories? Science. 2004;304:19328. DOIPubMedGoogle Scholar
  9. Lim  WL, Xing  H, Wong  KH, Wong  MC, Shao  YM, Ng  MH, The lack of an epidemiological link between HIV type 1 infections in Hong Kong and Mainland China. AIDS Res Hum Retroviruses. 2004;20:25962. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1204.050762

Related Links


Table of Contents – Volume 12, Number 4—April 2006

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Yi-Ming Arthur Chen, AIDS Prevention and Research Center, National Yang-Ming University, 155 Li-Nong St, Sec. 2, Taipei, Taiwan 112; fax: 886-2-2827-0576

Send To

10000 character(s) remaining.


Page created: January 23, 2012
Page updated: January 23, 2012
Page reviewed: January 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.